Retrospective analysis of ocular adverse events with Clobetasol.
作者信息
Wang Yu, Jorizzo Joseph L
机构信息
Department of Dermatology, Wake Forest University, Winston-Salem, North Carolina, USA.
Department of Dermatology, Weill Cornell Medicine, New York, USA.
出版信息
Dermatol Ther. 2022 Jul;35(7):e15574. doi: 10.1111/dth.15574. Epub 2022 May 29.
Abstract
摘要
相似文献
1
Retrospective analysis of ocular adverse events with Clobetasol.氯倍他索眼部不良事件的回顾性分析。
Dermatol Ther. 2022 Jul;35(7):e15574. doi: 10.1111/dth.15574. Epub 2022 May 29.
2
Topical corticosteroids and bullous pemphigoid.外用糖皮质激素与大疱性类天疱疮
Arch Dermatol. 2003 Feb;139(2):225-6.
3
Exogenous Cushing's syndrome induced by surreptitious topical glucocorticosteroid overdose in infants with diaper dermatitis.因偷偷过量外用糖皮质激素导致尿布皮炎的婴儿发生外源性库欣综合征。
J Pediatr Endocrinol Metab. 2007 Nov;20(11):1169-71. doi: 10.1515/jpem.2007.20.11.1169.
4
Exogenous Cushing Syndrome due to Topical Clobetasone use for Diaper Rash.因外用氯倍他索治疗尿布疹导致的外源性库欣综合征。
Indian Pediatr. 2016 Jan;53(1):76-7.
5
Trichostasis spinulosa: possible association with prolonged topical application of clobetasol propionate 0.05% cream.
Int J Dermatol. 2007 Sep;46(9):982-5. doi: 10.1111/j.1365-4632.2007.03271.x.
6
Unregulated use of clobetasol propionate.
Br J Dermatol. 2001 May;144(5):1095-6. doi: 10.1046/j.1365-2133.2001.04213.x.
7
Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
Ir Med J. 2005 Apr;98(4):118.
8
Clobetasol--a potent new topical corticosteroid.
Med Lett Drugs Ther. 1986 Jun 6;28(715):57-9.
9
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.一项关于0.05%丙酸氯倍他索泡沫剂治疗非头皮银屑病的随机、双盲、安慰剂对照研究。
Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x.
10
Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.婴儿因丙酸氯倍他索经皮吸收导致库欣综合征和肾上腺抑制。
Saudi Med J. 2001 Dec;22(12):1139-41.
引用本文的文献
1
Clobetasol propionate for post-cataract surgery pain and inflammation.丙酸氯倍他索用于白内障术后疼痛和炎症。
Ann Med Surg (Lond). 2024 Oct 7;86(11):6395-6398. doi: 10.1097/MS9.0000000000002619. eCollection 2024 Nov.
本文引用的文献
1
Psoriasis Pathogenesis and Treatment.银屑病发病机制与治疗。
Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475.
2
Cataracts.白内障
Prim Care. 2015 Sep;42(3):409-23. doi: 10.1016/j.pop.2015.05.012.
3
Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.局部用皮质类固醇的眼部副作用：皮肤科医生需要了解的内容。
Australas J Dermatol. 2015 Aug;56(3):164-9. doi: 10.1111/ajd.12292. Epub 2015 Mar 5.
4
The pathophysiology and treatment of glaucoma: a review.青光眼的病理生理学和治疗：综述。
JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192.
5
Osteonecrosis of the femoral head and glaucoma caused by topical corticosteroid application.因局部皮质类固醇应用导致的股骨头坏死和青光眼。
Mod Rheumatol. 2011 Dec;21(6):706-9. doi: 10.1007/s10165-011-0473-0. Epub 2011 Jun 21.
6
Acute irreversible corticol cataracts in prolonged topical corticosteriod overuse for chronic eczema.
Eye (Lond). 2009 Apr;23(4):984. doi: 10.1038/eye.2008.123. Epub 2008 Apr 25.
7
Glaucoma following congenital cataract surgery--the role of early surgery and posterior capsulotomy.先天性白内障手术后的青光眼——早期手术及后囊切开术的作用
BMC Ophthalmol. 2007 Sep 11;7:13. doi: 10.1186/1471-2415-7-13.
8
Pathogenesis and clinical features of psoriasis.银屑病的发病机制与临床特征
Lancet. 2007 Jul 21;370(9583):263-271. doi: 10.1016/S0140-6736(07)61128-3.
9
Psoriasis: epidemiology, clinical features, and quality of life.银屑病：流行病学、临床特征及生活质量
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. doi: 10.1136/ard.2004.033217.
10
Glaucoma induced by periorbital topical steroid use--a rare complication.
Clin Exp Dermatol. 2004 Nov;29(6):617-9. doi: 10.1111/j.1365-2230.2004.01610.x.
Zotero 插件